Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03118466 |
|---|---|
| Brief Title: | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia |
| First Submitted : | March 30, 2017 |
| First Submitted that Met QC Criteria : | April 17, 2017 |
| First Posted : | April 18, 2017 |
| Last Update Submitted that Met QC Criteria : | June 25, 2019 |
| Last Update Posted : | June 26, 2019 |